Discover open access scientific publications

Search, annotate, share and cite publications

Publications by María Q. Marín

An MVA Vector Expressing HIV-1 Envelope Under the Control of a Potent Vaccinia Virus Promoter as a Promising Strategy in HIV/AIDS Vaccine Design

Vaccines

English

Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B

English

Related publications

Enhanced Immunity to Human Immunodeficiency Virus (HIV) Envelope Elicited by a Combined Vaccine Regimen Consisting of Priming With a Vaccinia Recombinant Expressing HIV Envelope and Boosting With Gp160 Protein.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1993

English

Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use as a Novel HIV-1 Vaccine

Frontiers in Immunology

Allergy

Immunology

2018

English

Highly Attenuated Modified Vaccinia Virus Ankara (MVA) as an Effective Recombinant Vector: A Murine Tumor Model

English

B5-Deficient Vaccinia Virus as a Vaccine Vector for the Expression of a Foreign Antigen in Vaccinia Immune Animals

Virology

2007

English

Dendritic Cells Infected by Recombinant Rabies Virus Vaccine Vector Expressing HIV-1 Gag Are Immunogenic Even in the Presence of Vector-Specific Immunity

English

Mucosal Tissue Tropism and Dissemination of HIV-1 Subtype B Acute Envelope-Expressing Chimeric Virus

English

A Novel, Live-Attenuated Vesicular Stomatitis Virus Vector Displaying Conformationally Intact, Functional HIV-1 Envelope Trimers That Elicits Potent Cellular and Humoral Responses in Mice

PLoS ONE

Multidisciplinary

2014

English

SPI-1 Is a Missing Host-Range Factor Required for Replication of the Attenuated Modified Vaccinia Ankara (MVA) Vaccine Vector in Human Cells

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by María Q. Marín

An MVA Vector Expressing HIV-1 Envelope Under the Control of a Potent Vaccinia Virus Promoter as a Promising Strategy in HIV/AIDS Vaccine Design

Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B

Related publications

Enhanced Immunity to Human Immunodeficiency Virus (HIV) Envelope Elicited by a Combined Vaccine Regimen Consisting of Priming With a Vaccinia Recombinant Expressing HIV Envelope and Boosting With Gp160 Protein.

Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use as a Novel HIV-1 Vaccine

Highly Attenuated Modified Vaccinia Virus Ankara (MVA) as an Effective Recombinant Vector: A Murine Tumor Model

B5-Deficient Vaccinia Virus as a Vaccine Vector for the Expression of a Foreign Antigen in Vaccinia Immune Animals

Dendritic Cells Infected by Recombinant Rabies Virus Vaccine Vector Expressing HIV-1 Gag Are Immunogenic Even in the Presence of Vector-Specific Immunity

Mucosal Tissue Tropism and Dissemination of HIV-1 Subtype B Acute Envelope-Expressing Chimeric Virus

A Novel, Live-Attenuated Vesicular Stomatitis Virus Vector Displaying Conformationally Intact, Functional HIV-1 Envelope Trimers That Elicits Potent Cellular and Humoral Responses in Mice

SPI-1 Is a Missing Host-Range Factor Required for Replication of the Attenuated Modified Vaccinia Ankara (MVA) Vaccine Vector in Human Cells